Skip to main content

Table 4 Comparison of histology impact between studies in locally advanced cervical cancer in the last decade

From: Tumor histology is an independent prognostic factor in locally advanced cervical carcinoma: A retrospective study

Authors

Years of patient inclusion

Type of study

Clinical stage

N

SSC/AC proportion %

OS

P-value

Galic et al. (2012)

1988–2005

Retrospective

multicenter

IIB-IVA

10,217

84.2/10.8/5.0a

32.5/17.9/29.2

0.014b

Katanyoo et al. (2012)

1995–2008

Retrospective

IIB-IVA

423

66.7/33.3

61.7/59.9

0.191

Intaraphet et al. (2013)

1995–2011

Retrospective

I-IV

1978

82.5/17.5

60/54.7

 < 0.001

Rose et al. 2014

 

Retrospective 5 clinical trials

IB2-IVA

1671

89.1/10.9c

–––––––

0.459

Chen et al. (2014)

1995–2009

Retrospective

IIB-IVA

229

84.7/15.3c

58.1/41.3

0.090

Yun Lee et al. (2015)

1993–2012

Retrospective

 

3156

85.0/15.0

–––––––-

0.003

Zhou et al. (2017)

1988–2013

Retrospective

multicenter

I-IV

8751

86/10.6/3.4a

51.1/40.3

 < 0.001

Yokoi et al. (2017)

1993–2014

Retrospective

IIB-IVA

249

90.4/9.6

58.6/26.7

0.004

Seamon et a (2017)

1999–2012

Retrospective 3 clinical trials treated whit chemotherapy doublets

IVBξ

781

77/23

10.3/15.1

0.093

Cheng Yin et al. (2018)

2004–2016

Retrospective

Single center

IB2-IVA

181

83.4/16.5

78.6/46.0

 < 0.001

Hu et al. (2018)

2011–2014

Retrospective

IB-IVA

815

91.2/8.7

85.2/74.4

0.005

Jonska-Gmyrek et al. (2019)

2004–2012

Retrospective

IIB

IIIA-IIIB

161

67.7/32.3

81.7/62.8

73.1/33.6

0.03

0.005

Current Study

2005–2014

Retrospective

Single center

IB2-IVA

1291

1154/137

74.3/60.0

0.004

  1. a Adenosquamous carcinoma bcalculated only for IIIB clinical Stage cAC + adenosquamous carcinoma